P-1685. Knowledge, Attitudes, and Practice of Healthcare Providers Regarding Oral Antibiotic Use in a Health System
Abstract
Abstract Background Treating infections with oral (PO) antibiotics is associated with reduced risk for catheter associated infections, costs, and length of stay. However, barriers in appropriate transition to PO antibiotics exist. Intravenous versus oral antibiotics by treatment indication The most common treatment indications were pneumonia, cellulitis, bacteremia, and urinary tract infection. A lower proportion of patients with cystitis and bacteremia were transitioned to oral antibiotics compared to other indications. Methods This study aims to understand the knowledge, attitudes, and practice of healthcare providers regarding PO antibiotics. This is a cross-sectional, descriptive survey followed by a multi-center, retrospective chart review. A web-based questionnaire was distributed electronically and promoted during meetings to healthcare providers. The retrospective chart review included admitted adult patients who were administered antibiotics for targeted infections. Patients that were pregnant, incarcerated, had inadequate PO absorption, or lack of source control were excluded. The primary outcome was to identify areas for antimicrobial stewardship intervention. This was done by identifying discordances between provider knowledge or attitudes and prescribing practices. Descriptive statistics and regression analyses were conducted. Results The survey collected 119 total responses from pharmacists (47.1%), physicians (36.1%), medical residents (5.9%), and advanced…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.